Articles
-
Who Are the Winners in the No Surprises Act?
With the No Surprises Act set to take effect January 1, HHS is resisting a push from some doctor groups to weaken implementation rules of the legislation, and that’s a good thing. The law is a big win for patients, employers, and consumers.
Categorized in -
New USC Schaeffer Research Maps State and Federal Responses to the Opioid Crisis During the COVID-19 Pandemic
While all states and D.C. have adopted at least one policy related to treatment access for patients suffering from opioid addiction, no state adopted all the policies analyzed, leaving potential barriers in place.
Categorized in -
Middlemen, Not Drug Companies, Are Pushing Up Insulin Prices, and Congress Doesn’t Have the Right Plan to Fight Back
Congress should take advantage of the current political climate and start reining in the intermediaries in the drug distribution system.
Categorized in -
Pilot Funding Available for Researchers of Alzheimer’s, Aging
Pilot funding amounts range from $25,000 to up to $45,000. An informational session on the application process will be held over zoom on Thursday, December 9, 2021, at 10:00 a.m. pacific.Â
-
More than Half of Insulin Expenditures Going to Middlemen, New USC Schaeffer Study Finds
Schaeffer research offers one of the most comprehensive looks at the insulin distribution chain and shows which players are profiting, and by how much, from selling insulin.
Categorized in -
Hesitancy Plays Increasing Role in Vaccine Coverage Disparities Despite Wide Availability
Social vulnerability was also independently associated with widening disparities in county-level coverage, signaling the need for unique, targeted interventions.
Categorized in -
How COVID Can Help Us Refocus on the How and Why of Value Assessment
The limitations of conventional approaches to value assessment are particularly clear when reflecting on our experience with the COVID-19 pandemic.
Categorized in -
Economic Incentives for Administrative Simplification
In the US health care system, payers, health systems, physicians, other clinicians, drug companies, pharmacies, and pharmacy benefit managers all earn more revenue because of administrative complexity.
Categorized in -
Schaeffer Health Economist Elected to the National Academy of Medicine
Schaeffer Center Senior Fellow Paul Ginsburg’s contributions to health policy include pivotal improvements to Medicare and our understanding of insurance and provider markets.